These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 24595069

  • 1. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
    De Gregori S, Minella CE, De Gregori M, Tinelli C, Ranzani GN, Govoni S, Allegri M, Regazzi M.
    Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
    [Abstract] [Full Text] [Related]

  • 2. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C, Joel S, Patel N, Baksh A, Slevin M.
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [Abstract] [Full Text] [Related]

  • 3. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
    Van Crugten JT, Somogyi AA, Nation RL, Reynolds G.
    Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
    Perreault S, Choinière M, du Souich PB, Bellavance F, Beauregard G.
    Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
    [Abstract] [Full Text] [Related]

  • 5. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
    Du X, Skopp G, Aderjan R.
    Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
    [Abstract] [Full Text] [Related]

  • 6. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
    Penson RT, Joel SP, Bakhshi K, Clark SJ, Langford RM, Slevin ML.
    Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
    Romberg R, Olofsen E, Sarton E, den Hartigh J, Taschner PE, Dahan A.
    Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
    [Abstract] [Full Text] [Related]

  • 8. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P, Fougner B, Kaasa S.
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
    Pauli-Magnus C, Hofmann U, Mikus G, Kuhlmann U, Mettang T.
    Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
    [Abstract] [Full Text] [Related]

  • 10. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
    Barrett DA, Barker DP, Rutter N, Pawula M, Shaw PN.
    Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA, Nation RL, Olweny C, Tsirgiotis P, van Crugten J, Milne RW, Cleary JF, Danz C, Bochner F.
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients.
    Ihmsen H, Schüttler J, Jeleazcov C.
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.
    Klepstad P, Kaasa S, Borchgrevink PC.
    Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
    Moolenaar F, Meijler WJ, Frijlink HW, Visser J, Proost JH.
    Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
    Stuart-Harris R, Joel SP, McDonald P, Currow D, Slevin ML.
    Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.